Chemists are well trained in perceiving 2D molecular sketches. On the side of computer assistance, the automated generation of such sketches becomes very difficult when it comes to multi-molecular arrangements such as protein-ligand complexes in a drug design context. Existing solutions to date suffer from drawbacks such as missing important interaction types, inappropriate levels of abstraction and layout quality.
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During the last few years we have developed PoseView [1, 2] , a tool which displays molecular complexes incorporating a simple, easy-to-perceive arrangement of the ligand and the amino acids towards which it forms interactions. Resulting in atomic resolution diagrams, PoseView operates on a fast tree re-arrangement algorithm to minimize crossing lines in the sketches. Due to a de-coupling of interaction perception and the drawing engine, PoseView can draw any interactions determined by either distance-based rules or the FlexX interaction model (which itself is user accessible). Owing to the small molecule drawing engine 2Ddraw [3] , molecules are drawn in a textbook-like manner following the IUPAC regulations.
The tool has a generic file interface for other complexes than protein-ligand arrangements. It can therefore be used as well for the display of, e.g., RNA/DNA complexes with small molecules. For batch processing, an additional command line interface is available; output can be provided in various formats, amongst them gif, ps, svg and pdf.
Besides the underlying interaction models, we will present new algorithmic approaches, assess usability issues and a large-scale validation study on the PDB. 
